Human sebaceous tumors harbor inactivating mutations in LEF1

Author:  ["Hikaru Takeda","Stephen Lyle","Alexander J F Lazar","Christos C Zouboulis","Ian Smyth","Fiona M Watt"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

We found that one-third of human sebaceous tumors examined had double-nucleotide substitutions in the same LEF1 allele, irrespective of DNA mismatch repair status. The mutations impaired both LEF1 binding to β-catenin and transcriptional activation, and are the first tumor-associated mutations that inactivate Wnt signaling. Mutant LEF1 not only inhibited expression of β-catenin target genes but also stimulated expression of sebocyte markers, suggesting that it may determine the differentiated characteristics of sebaceous tumors.

Cite this article

Takeda, H., Lyle, S., Lazar, A. et al. Human sebaceous tumors harbor inactivating mutations in LEF1. Nat Med 12, 395–397 (2006). https://doi.org/10.1038/nm1386

View full text

>> Full Text:   Human sebaceous tumors harbor inactivating mutations in LEF1

Induction of leptin resistance through direct interaction of C-reactive protein with leptin

Role of matrix metalloproteinases in delayed cortical responses after stroke